$5.54
▼ -1.9% Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Here's Why You Should Add Savara Stock to Your Portfolio Now
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline
Savara Insider Sold Shares Worth $2,241,432, According to a Recent SEC Filing
Overview
52-week range
$1.98
$7.00
71% of range
Avg surprise (last 3)
-7.9%
Avg reaction (last 2)
-1.2%
0% positive
Latest IV / EM
62%
EM ±14.2% · $6 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.15 | $-0.14 | -7.1% | -25.0% | -0.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.14 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.14 | $-0.12 | -16.7% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.12 | $-0.12 | 0.0% | — | -1.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.12 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.11 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.10 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.07 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.14 | -$0.14 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-39M | — | $-30M | $-31M | $-28M | — | $-26M | $-23M |
| Net income | $-37M | — | $-30M | $-30M | $-27M | — | $-24M | $-22M |
| EPS (diluted) | $-0.15 | — | $-0.14 | $-0.14 | $-0.12 | — | $-0.11 | $-0.12 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $39M | $33M | $16M | $17M | $20M | $15M | $21M | $24M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $209M | $242M | $128M | $151M | $177M | $202M | $226M | $128M |
| Total assets | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M |
| Long-term debt | $30M | $30M | $30M | $30M | $30M | $27M | $27M | $26M |
| Total liabilities | $46M | $50M | $47M | $43M | $41M | $41M | $39M | $38M |
| Total equity | $176M | $203M | $94M | $120M | $148M | $171M | $199M | $102M |